Renaissance Technologies (RenTech)'s VMD Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 442,200 shares of Viemed Healthcare, Inc. (VMD) worth $4.07 M, representing 0.01% of the portfolio. First purchased in 2019-Q3, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 234,002 shares. Largest reduction occurred in Q4 2021, reducing 285,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Viemed Healthcare (VMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Viemed Healthcare (VMD) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,400 | Add 0.32% | 442,200 | $9.21 |
| Q4 2025 | -6,200 | Reduce 1.39% | 440,800 | $7.43 |
| Q3 2025 | +36,700 | Add 8.94% | 447,000 | $6.79 |
| Q2 2025 | +25,900 | Add 6.74% | 410,300 | $6.91 |
| Q1 2025 | +11,400 | Add 3.06% | 384,400 | $7.28 |
| Q4 2024 | +8,400 | Add 2.30% | 373,000 | $8.02 |
| Q3 2024 | -74,100 | Reduce 16.89% | 364,600 | $7.33 |
| Q2 2024 | +147,900 | Add 50.86% | 438,700 | $6.55 |
| Q1 2024 | +6,800 | Add 2.39% | 290,800 | $9.43 |
| Q4 2023 | -42,700 | Reduce 13.07% | 284,000 | $7.85 |
| Q3 2023 | +82,400 | Add 33.73% | 326,700 | $6.73 |
| Q2 2023 | +68,900 | Add 39.28% | 244,300 | $0.01 |
| Q1 2023 | +300 | Add 0.17% | 175,400 | $0.01 |
| Q4 2022 | -89,300 | Reduce 33.77% | 175,100 | $0.01 |
| Q3 2022 | +5,500 | Add 2.12% | 264,400 | $6.00 |
| Q2 2022 | -95,756 | Reduce 27.00% | 258,900 | $5.38 |
| Q1 2022 | +186,256 | Add 110.60% | 354,656 | $5.00 |
| Q4 2021 | -285,400 | Reduce 62.89% | 168,400 | $5.22 |
| Q3 2021 | +32,000 | Add 7.59% | 453,800 | $5.56 |
| Q2 2021 | +105,198 | Add 33.23% | 421,800 | $7.15 |
| Q1 2021 | +234,002 | Add 283.30% | 316,602 | $10.15 |
| Q4 2020 | +68,900 | Add 502.92% | 82,600 | $7.76 |
| Q3 2020 | -48,500 | Reduce 77.97% | 13,700 | $8.61 |
| Q2 2020 | +41,700 | Add 203.41% | 62,200 | $9.60 |
| Q1 2020 | -166,900 | Reduce 89.06% | 20,500 | $4.78 |
| Q4 2019 | +174,300 | Add 1330.53% | 187,400 | $6.26 |
| Q3 2019 | +13,100 | New Buy | 13,100 | $6.87 |
Renaissance Technologies (RenTech)'s Viemed Healthcare Investment FAQs
Renaissance Technologies (RenTech) first purchased Viemed Healthcare, Inc. (VMD) in Q3 2019, acquiring 13,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Viemed Healthcare, Inc. (VMD) for 27 quarters since Q3 2019.
Renaissance Technologies (RenTech)'s largest addition to Viemed Healthcare, Inc. (VMD) was in Q1 2021, adding 316,602 shares worth $3.21 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 442,200 shares of Viemed Healthcare, Inc. (VMD), valued at approximately $4.07 M.
As of the Q1 2026 filing, Viemed Healthcare, Inc. (VMD) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Viemed Healthcare, Inc. (VMD) was 453,800 shares, as reported at the end of Q3 2021.